Skip to content


  • Case Report
  • Open Access

Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: a case report

  • 1Email author,
  • 2,
  • 2,
  • 3,
  • 4 and
  • 2
Cases Journal20092:204

  • Received: 23 September 2009
  • Accepted: 18 November 2009
  • Published:


Radiotherapy has a significant impact on the local tumor environment and its distant component. Abscopal effect is the bystander effect of radiotherapy observed at a site distant to that irradiated within the same subject. Abscopal effect even though described, is not a common clinical event. We report a documented observation of abscopal effect in a patient of Chronic Lymphocytic Leukemia during radiation therapy.


  • Chronic Lymphocytic Leukemia
  • Chlorambucil
  • Bystander Effect
  • Procarbazine
  • Papillary Adenocarcinoma


The Abscopal effect is the effect of radiation therapy sometimes observed as response of tumour masses remote from the site of irradiation [1]. The term "abscopal effect" caused by radiotherapy was first coined by Mole in 1953 [2]. The word abscopal is derived from Latin ab means "position away from" and scopos meaning "a target for shooting at."

Much of the observed physiological Abscopal effect has been associated with splenic irradiaition[1]. Abscopal effect even though described, is not a common clinical event after radiotherapy, there have been reports of such effects in variety of malignancies including lymphoma, papillary adenocarcinoma, melanoma, adenocarcinoma of the esophagus, chronic lymphocytic leukemia, and hepatocellular carcinoma [310].

Case presentation

A 65 year old female patient, a known case of Chronic Lymphocytic Leukemia since two years, presented to us with a massive right axillary lymphadenopathy with severe pain and neurovascular pressure effects in the axilla.

This patient at diagnosis, about two years back had presented with Right Axillay lymphadenopathy (approx 6-8 cms, Multiple) and was initially treated with chemotherapy COPP (cyclophosphamide, vincristine, procarbazine, prednisone) regimen for 3 cycles and then switched over to Chlorambucil & prednisone. Since she had disease progression in spite of active treatment all Chemotherapy drugs were stopped two months prior to presentation with us and symptomatic care with analgesics instituted.

On examination the patient had a massive right axillary lymphadenopathy, with multiple matted lymph nodes. The biggest node measured 14 × 12 × 10 cms with other axillary nodes ranging from 5 to 4 cms. She also had multiple (>1 cms) bilateral cervical lymphnodes (the largest 2 × 2 cms) at presentation were located in the right level II neck region away from the field of radiotherapy. She had no generalized lymphadenopathy or splenomegaly.

The patient was treated with local field Radiation therapy to axilla with anterior & posterior parallel opposed local fields, to a dose of 2400 cGy in 12 fractions, 5 fractions per week (Figure 1).
Figure 1
Figure 1

Massive Axillary Lymphnode is marked in dotted line, the radiotherapy field is shaped like a rectangle and one of the multiple bilateral neck lymphnode (2 × 2 cms) away from the radiotherapy field is marked as small circle in the neck.

One week after radiotherapy the lymphnodes in the neck which was unirradiated, and away from the field of radiotherapy, started regressing and by the end of two weeks of radiotherapy the lymphnodes in the neck had shown complete regression due to abscopal effect and the axillary node had a partial response with subjective improvement in symptoms and performance status (Figure 2). 6 months after radiation therapy the patient continues to have sustained palliation in the irradiatied and distant site.
Figure 2
Figure 2

the irradiatied axillary lymph node shows greater than 50% response at the end of radiotherapy and the unirridiated neck node away from the site of radiation has completely disappeared due to Abscopal effect.

Discussion & Conclusion

Radiotherapy has a significant impact on the local microenvironment of tissues within the radiation portal. Cells treated with Ionizing radiation sustain damage to its nuclear & cytoplasmic components, inducing of apoptosis, up-regulation transcription factors. Resulting in increased vascular permeability, altered cytokine levels and local inflammation [11, 12].

Radiotherapy to one cell has direct impact on an adjacent cell resulting in bystander effect [13, 14]. There have been two main theories proposed to explain the abscopal antitumor effect. The first applies to leukemias and lymphomas, it is hypothesized that during splenic irradiation diseased lymphocytes circulate through the irradiated volume (spleen), as the splenic size decreases the remotely located masses also decrease in size, giving an impression of a systemic antitumor effect from local treatment [1, 4, 5]. The second applies to solid tumors, it is postulated that local radiation induces a release of mitotic inhibitors (cytokines) into the circulation that mediate a systemic antitumor effect. It has been demonstrated that an elevation of circulating tumor necrosis factor after radiotherapy that coincided with the regression of a hepatocellular carcinoma situated away from the radiation field [2, 10].

Others proposed hypothesis is that the abscopal effect is mediated by the immune system. Irradiation of tumour in one site induces release of circulating tumor antigen or inflammatory factors that may then mediate an augmented immune response against unirradiated, malignant lesions expressing similar tumor antigens. It has been shown that local radiotherapy increases the activity of natural killer cells [15, 16].

In our patient by virtue of this unusual presentation, we were able to predict and observe the rare abscopal effect in the site distant from the site of irradiation. Irradiation of the disease in the axilla resulted in tumor mass regression in untreated distant site.




Padma G - helped in literature survey

Authors’ Affiliations

Department of Physiology, M.S. Ramaiah Medical College, Bangalore, India
Department of Radiation Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India
Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India
Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bangalore, India


  1. Robert Andrews J: The Radiobiology of Human cancer Radiotherapy. University Park Press, Baltimore, 374-375. 2Google Scholar
  2. Mole RH: Whole body irradiation-radiobiology or medicine?. Br J Radiol. 1953, 26: 234-241. 10.1259/0007-1285-26-305-234.View ArticlePubMedGoogle Scholar
  3. Nobler M: The abscopal effect in malignant lymphoma and its relationship tolymphocyte circulation. Radiology. 1969, 93: 410-412.View ArticlePubMedGoogle Scholar
  4. Antoniades J, Brady L, Lightfoot D: Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int J Radiat Oncol Biol Phys. 1977, 2: 141-147.View ArticlePubMedGoogle Scholar
  5. Rees GJ: Abscopal regression in lymphoma: a mechanism in common with total body irradiation? Clin. Radiol. 1981, 32: 475-480.Google Scholar
  6. Ehlers G, Fridman M: Abscopal effect of radiation in papillary adenocarcinoma. Br J Radiol. 1973, 46: 220-222. 10.1259/0007-1285-46-543-220.View ArticlePubMedGoogle Scholar
  7. Kingsley D: An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol. 1975, 48: 863-866. 10.1259/0007-1285-48-574-863.View ArticlePubMedGoogle Scholar
  8. Rees G, Ross C: Abscopal regression following radiotherapy for adenocarcinoma. Br J Radiol. 1983, 56: 63-66. 10.1259/0007-1285-56-661-63.View ArticlePubMedGoogle Scholar
  9. Sham R: The abscopal effect and chronic lymphocytic leukemia. Am J Med. 1995, 98: 307-308. 10.1016/S0002-9343(99)80380-5.View ArticlePubMedGoogle Scholar
  10. Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, Kinoshita H, Masuda J, Hazama H, Sakamoto I, Kohno S: Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut. 1998, 43: 575-577.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Jolles B, Harrison RG: Radiation skin reaction and depletion and restoration of body immune response. Nature (Lond.). 1963, 198: 1216-1217. 10.1038/1981216a0.View ArticleGoogle Scholar
  12. Hall E: Radiobiology for the radiologist. 2000, Philadelphia: Lippincott, Williams and Wilkins, 588-5Google Scholar
  13. Trott KR: Non-targeted radiation effects in radiotherapy-roles of radiation-induced genomic instability and of the bystander effect in cancer cure by radiotherapy. Acta Oncologia. 2001, 40: 976-980. 10.1080/02841860152708260.View ArticleGoogle Scholar
  14. Hartford A, Gohongi T, Fukumura D, Jain R: Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res. 2000, 60: 2128-2131.PubMedGoogle Scholar
  15. Uchida A, Mizutani Y, Nagamuta M, Ikenaga M: Elevation of sensitivity of tumor cells and lytic function of NK cells. Immunopharmacol. Immunotoxicol. 1989, 11: 507-519. 10.3109/08923978909005381.View ArticlePubMedGoogle Scholar
  16. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. 2004, 58 (3): 862-870.Google Scholar


© Lakshmanagowda et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.